Press Releases October 1, 2026 08:00 AM

Stryker to announce third quarter 2026 financial results

Stryker Corporation schedules webcast for Q3 2026 financial results announcement

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
SYK

Stryker Corporation, a global leader in medical technologies, will release its third quarter 2026 financial results on October 29, 2026, followed by a webcast to discuss the performance. A press release with summary financial information will be issued shortly before the webcast, providing investors and analysts access to the company's latest financial metrics.

Stryker to announce third quarter 2026 financial results
SYK
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Stryker to announce Q3 2026 financial results on October 29, 2026.
  • The company will host a live webcast for earnings discussion at 4:30 p.m. Eastern time.
  • Stryker is a leader in MedSurg, Neurotechnology, and Orthopaedics, impacting healthcare outcomes globally.

Portage, Michigan, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, October 29, 2026, to discuss its third quarter 2026 financial results. The live webcast can be accessed at Stryker - Events & Presentations. An archive of the webcast will also be available at Stryker’s website beginning approximately two hours after the live call ends.

An accompanying press release that includes summary financial information for the third quarter will be issued at approximately 4:05 p.m. (Eastern time) and available at Stryker - Press Releases on the day of the webcast.

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

Contacts

For investor inquiries:
Nick Mead, Vice President, Investor Relations at 269-385-2600 or [email protected]

For media inquiries:
Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or [email protected]


Risks

  • Earnings performance could be below market expectations, potentially affecting stock price.
  • Economic or healthcare sector changes impacting medical technology demand.
  • Regulatory or supply chain challenges influencing future financial results.

More from Press Releases

Phaos Technology Holdings (Cayman) Limited Announces Entry Into Securities Purchase Agreement for an Equity Facility of Up to US$10 Million Oct 1, 2026 American Airlines Group announces webcast of third-quarter 2026 financial results Oct 1, 2026 Progress Software Connects Enterprise Knowledge Across Business Systems with New Agentic RAG Capabilities Oct 1, 2026 Unity Bank Celebrates 20th Anniversary Charity Car Show Benefiting Family Promise Oct 1, 2026 Gogo Responds to Court’s Post-Trial Ruling in SmartSky Litigation Oct 1, 2026